Shanghai Institute of Pharmaceutical Industry

Alibaba Group Holding Limited

China State Institute of Pharmaceutical Industry

Shanghai Modern Pharmaceutical Co., Ltd.

Xuejun Wu

Quanhai Liu

Minyu Liu

Ying Liu

Zhen Zhang

Li Cai

Renhai Chen

Xiaoling Huang

Lin Xiao

Yifang Deng

Haiyan Sun

Chungang Li

Wei Wu

Jun He

Guoping Wang

Jinyao Chen

Guobin Ren

Yan Qin

Jian Hou

Li Yin

Zhiru Xu

Shuai Zhao

Lin Yao

Zhenpeng Yu

Shenrong Tang

Gouping Wang

Liling Jin

Xiangduan Tan

Tian Zhang

Mianli Pan

An acceleration unit including a primary core and a secondary core is provided. The primary core includes a first on-chip memory, a primary core sequencer adapted to decode a received first cross-core copy instruction, and a primary core memory copy engine adapted to acquire a first operand from a first address in the first on-chip memory and copy the acquired first operand to a second address in a second on-chip memory of the secondary core. Further, the secondary core includes a second on-chip memory, a secondary core sequencer adapted to decode a received second cross-core copy instruction, and a secondary core memory copy engine adapted to acquire the first operand from the second address in the second on-chip memory and copy the acquired first operand back to the first address in the first on-chip memory.

Executing cross-core copy instructions in an accelerator to temporarily store an operand that cannot be accommodated by on-chip memory of a primary core into a secondary core

Disclosed are amide compounds, preparation method and uses thereof, specifically, the compounds represented by formula I or pharmaceutically acceptable salts, wherein R, R, R, R, R, Q, X and n are defined as in the description. Also disclosed are a method for preparing the compounds of formula I, a composition containing the compounds, and the uses of the same in the preparation of medicaments for regulating blood lipid and/or preventing gallstone. The compounds of formula I disclosed in the present invention have stability in vitro, good solubility in the pharmaceutical organic solvents and favorable bioavailability in animals.

Amide compound, preparation method and uses thereof

An amorphous asiatic tromethamine salt and the preparation method thereof. The method includes the steps of: (1) dissolving asiatic acid in an organic solvent; step (2) mixing with tromethamine; step (3) stirring and salifying the same, and then removing the organic solvent. The method for preparing the amorphous asiatic tromethamine salt is easy and effective, and the water solubility and bioavailability of the asiatic tromethamine salt thus obtained are greatly compared with the prior art.

Amorphous asiatic tromethamine salt and preparation method thereof

The invention discloses a dithiolopyrrolone compound represented by formula I or its pharmaceutically acceptable salts, wherein X, R, R, R, Rare defined as in the description. The invention also discloses the preparation of such compounds, and the use of such compounds in preparation of medicaments for increasing peripheral white blood cells and in preparation of ancillary medicaments for inhibiting the decrease of peripheral white blood cells in radiotherapy or chemotherapy.

Dithiolopyrrolone compounds, the preparation and the use thereof

Growing community of inventors

Shanghai, China

Xuejun Wu